Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

351 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multiple Mucosa-associated Lymphoid Tissue Lymphoma of the Trachea.
Minami D, Ando C, Sato K, Moriwaki K, Sugahara F, Nakasuka T, Iwamoto Y, Fujiwara K, Shibayama T, Yonei T, Sato T. Minami D, et al. Among authors: shibayama t. Intern Med. 2017 Nov 1;56(21):2907-2911. doi: 10.2169/internalmedicine.8269-16. Epub 2017 Sep 25. Intern Med. 2017. PMID: 28943536 Free PMC article.
Interstitial lung disease in Japanese patients with non-small cell lung cancer receiving gefitinib: an analysis of risk factors and treatment outcomes in Okayama Lung Cancer Study Group.
Hotta K, Kiura K, Tabata M, Harita S, Gemba K, Yonei T, Bessho A, Maeda T, Moritaka T, Shibayama T, Matsuo K, Kato K, Kanehiro A, Tanimoto Y, Matsuo K, Ueoka H, Tanimoto M. Hotta K, et al. Among authors: shibayama t. Cancer J. 2005 Sep-Oct;11(5):417-24. doi: 10.1097/00130404-200509000-00010. Cancer J. 2005. PMID: 16259873
A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II study.
Tabata M, Kozuki T, Ueoka H, Kiura K, Harita S, Tada A, Shibayama T, Takigawa N, Yonei T, Gemba K, Segawa Y, Kishino D, Tada S, Hiraki S, Tanimoto M; Okayama Lung Cancer Study Group. Tabata M, et al. Among authors: shibayama t. Cancer Chemother Pharmacol. 2007 Jun;60(1):53-9. doi: 10.1007/s00280-006-0346-y. Epub 2006 Sep 29. Cancer Chemother Pharmacol. 2007. PMID: 17009034 Clinical Trial.
Sex difference in the influence of smoking status on the responsiveness to gefitinib monotherapy in adenocarcinoma of the lung: Okayama Lung Cancer Study Group experience.
Hotta K, Kiura K, Takigawa N, Kuyama S, Segawa Y, Yonei T, Gemba K, Aoe K, Shibayama T, Matsuo K, Kamei H, Fujiwara Y, Bessho A, Moritaka T, Sugimoto K, Tabata M, Ueoka H, Tanimoto M. Hotta K, et al. Among authors: shibayama t. J Cancer Res Clin Oncol. 2009 Jan;135(1):117-23. doi: 10.1007/s00432-008-0431-1. Epub 2008 Jul 11. J Cancer Res Clin Oncol. 2009. PMID: 18618142
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Segawa Y, Kiura K, Takigawa N, Kamei H, Harita S, Hiraki S, Watanabe Y, Sugimoto K, Shibayama T, Yonei T, Ueoka H, Takemoto M, Kanazawa S, Takata I, Nogami N, Hotta K, Hiraki A, Tabata M, Matsuo K, Tanimoto M. Segawa Y, et al. Among authors: shibayama t. J Clin Oncol. 2010 Jul 10;28(20):3299-306. doi: 10.1200/JCO.2009.24.7577. Epub 2010 Jun 7. J Clin Oncol. 2010. PMID: 20530281 Clinical Trial.
351 results